Literature DB >> 20447532

Copeptin improves early diagnosis of acute myocardial infarction.

Till Keller1, Stergios Tzikas, Tanja Zeller, Ewa Czyz, Lars Lillpopp, Francisco M Ojeda, Alexander Roth, Christoph Bickel, Stephan Baldus, Christoph R Sinning, Philipp S Wild, Edith Lubos, Dirk Peetz, Jan Kunde, Oliver Hartmann, Andreas Bergmann, Felix Post, Karl J Lackner, Sabine Genth-Zotz, Viviane Nicaud, Laurence Tiret, Thomas F Münzel, Stefan Blankenberg.   

Abstract

OBJECTIVES: Early identification of myocardial infarction in chest pain patients is crucial to identify patients at risk and to maintain a fast treatment initiation.
BACKGROUND: The aim of the current investigation is to test whether determination of copeptin, an indirect marker for arginin-vasopressin, adds diagnostic information to cardiac troponin in early evaluation of patients with suspected myocardial infarction.
METHODS: Between January 2007 and July 2008, patients with suspected acute coronary syndrome were consecutively enrolled in this multicenter study. Copeptin, troponin T (TnT), myoglobin, and creatine kinase-myocardial band were determined at admission and after 3 and 6 h.
RESULTS: Of 1,386 (66.4% male) enrolled patients, 299 (21.6%) had the discharge diagnosis of acute myocardial infarction, 184 (13.3%) presented with unstable angina, and in 903 (65.2%) an acute coronary syndrome could be excluded. Combined measurement of copeptin and TnT on admission improved the c-statistic from 0.84 for TnT alone to 0.93 in the overall population and from 0.77 to 0.9 in patients presenting within 3 h after chest pain onset (CPO) (p < 0.001). In this group the combination of copeptin with a conventional TnT provided a negative predictive value of 92.4%.
CONCLUSIONS: In triage of chest pain patients, determination of copeptin in addition to troponin improves diagnostic performance, especially early after CPO. Combined determination of troponin and copeptin provides a remarkable negative predictive value virtually independent of CPO time and therefore aids in early and safe rule-out of myocardial infarction. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447532     DOI: 10.1016/j.jacc.2010.01.029

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  61 in total

Review 1.  The ultimate nanoscale mincer: assembly, structure and active sites of the 20S proteasome core.

Authors:  W Heinemeyer; P C Ramos; R J Dohmen
Journal:  Cell Mol Life Sci       Date:  2004-07       Impact factor: 9.261

Review 2.  [Cardiac biomarkers in the critically ill].

Authors:  S Reith; N Marx
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-01-06       Impact factor: 0.840

3.  Acute coronary syndromes: New blood tests improve risk assessment and early diagnosis of AMI.

Authors:  Bryony M Mearns
Journal:  Nat Rev Cardiol       Date:  2010-08       Impact factor: 32.419

4.  Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin.

Authors:  Jasper Boeddinghaus; Tobias Reichlin; Thomas Nestelberger; Raphael Twerenbold; Yvette Meili; Karin Wildi; Petra Hillinger; Maria Rubini Giménez; Janosch Cupa; Lukas Schumacher; Marie Schubera; Patrick Badertscher; Sydney Corbière; Karin Grimm; Christian Puelacher; Zaid Sabti; Dayana Flores Widmer; Nicolas Schaerli; Nikola Kozhuharov; Samyut Shrestha; Tobias Bürge; Patrick Mächler; Michael Büchi; Katharina Rentsch; Òscar Miró; Beatriz López; F Javier Martin-Sanchez; Esther Rodriguez-Adrada; Beata Morawiec; Damian Kawecki; Eva Ganovská; Jiri Parenica; Jens Lohrmann; Andreas Buser; Dagmar I Keller; Stefan Osswald; Christian Mueller
Journal:  Clin Res Cardiol       Date:  2017-02-01       Impact factor: 5.460

5.  Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay.

Authors:  Tobias Reichlin; Raphael Twerenbold; Karin Wildi; Maria Rubini Gimenez; Nathalie Bergsma; Philip Haaf; Sophie Druey; Christian Puelacher; Berit Moehring; Michael Freese; Claudia Stelzig; Lian Krivoshei; Petra Hillinger; Cedric Jäger; Thomas Herrmann; Philip Kreutzinger; Milos Radosavac; Zoraida Moreno Weidmann; Kateryna Pershyna; Ursina Honegger; Max Wagener; Thierry Vuillomenet; Isabel Campodarve; Roland Bingisser; Òscar Miró; Katharina Rentsch; Stefano Bassetti; Stefan Osswald; Christian Mueller
Journal:  CMAJ       Date:  2015-04-13       Impact factor: 8.262

6.  Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey.

Authors:  Fred S Apple; Lyn M Steffen; Lesly A Pearce; MaryAnn M Murakami; Russell V Luepker
Journal:  Clin Chem       Date:  2012-03-19       Impact factor: 8.327

Review 7.  [ESC guidelines 2020: acute coronary syndrome without persistent ST-segment elevation : What is new?]

Authors:  Holger Thiele; Alexander Jobs
Journal:  Herz       Date:  2021-02       Impact factor: 1.443

8.  A multicentre analysis of troponin use in clinical practice.

Authors:  J D Groarke; L Browne; R Margey; H A McCann; G J Blake; D D Sugrue; N G Mahon
Journal:  Ir J Med Sci       Date:  2012-09-29       Impact factor: 1.568

9.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

10.  Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes.

Authors:  Dariush Afzali; Michael Erren; Hermann-Joseph Pavenstädt; Jörn Ole Vollert; Sabine Hertel; Johannes Waltenberger; Holger Reinecke; Pia Lebiedz
Journal:  Clin Res Cardiol       Date:  2013-05-23       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.